In‐depth proteomic analysis reveals unique subtype‐specific signatures in human small‐cell lung cancer

Abstract

We report for the first time, the protein expression differences among SCLC subtypes. By shedding light on potential subtype-specific therapeutic vulnerabilities and diagnostic biomarkers, our results may contribute to a better understanding of SCLC biology and the development of novel therapies.